Dr. Rafique is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204Phone+1 980-442-2000
Summary
- Dr. Amina Rafique is a Pediatric Hematology & Oncology Specialist based in New Orleans, LA, with additional subspecialties in coagulation disorder hematology, hematologic oncology, and platelet disorder hematology. She completed her Pediatric Hematology/Oncology fellowship and Pediatrics residency at the University of Illinois College of Medicine in Chicago, followed by a year in Bone Marrow Transplant at UPMC Children's Hospital of Pittsburgh. Dr. Rafique is currently the Division Head at Tulane Medical Center. She was also involved in a clinical trial of SEVENFACT® for bleeding events in hemophilia patients with inhibitors, serving as the contact and principal investigator.
Education & Training
- UPMC Children's Hospital of PittsburghBone Marrow Transplant , 2015 - 2016
- University of Illinois College of Medicine at ChicagoFellowship, Pediatric Hematology/Oncology, 2012 - 2015
- University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 2009 - 2012
- King Edward Medical UniversityClass of 2004
Certifications & Licensure
- NC State Medical License 2023 - 2025
- TX State Medical License 2023 - 2024
- LA State Medical License 2016 - 2023
- IL State Medical License 2009 - 2017
- MO State Medical License 2015 - 2016
- PA State Medical License 2015 - 2016
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors Start of enrollment: 2021 Jun 28
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsRiociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.Mark T Gladwin, Victor R Gordeuk, Payal C Desai, Caterina Minniti, Enrico M Novelli
The Lancet. Haematology. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: